The trajectory of Viagra, formerly marketed by copyright, presents a fascinating case study for investors considering the drug sector. Despite its groundbreaking success and creation of vast in sales, the intellectual property expiration has opened the way for alternative medications, significantly reducing income opportunities. This change raises